Director Dealing | 21-May-2025 | 07:00 | RNS |
Partnership with NHS Cancer Vaccine Launch Pad | 14-Apr-2025 | 07:00 | RNS |
Scancell to present at 2025 AACR Annual Meeting | 01-Apr-2025 | 07:00 | RNS |
Issue of share options | 20-Feb-2025 | 07:00 | RNS |
Scancell presenting at AACR IO conference | 17-Feb-2025 | 07:00 | RNS |
Interim Results | 30-Jan-2025 | 07:00 | RNS |
Notice of Interim Results | 23-Jan-2025 | 07:00 | RNS |
Modi-1 Vaccine Achieves Early Clinical Validation | 09-Jan-2025 | 07:00 | RNS |
Result of Retail Offer and Total Voting Rights | 09-Dec-2024 | 11:41 | RNS |
Result of Placing and Subscription | 05-Dec-2024 | 12:39 | RNS |
Retail Offer for up to £1 million | 04-Dec-2024 | 18:03 | RNS |
Proposed fundraise in excess of £8.5 million | 04-Dec-2024 | 17:59 | RNS |
Second Commercial License Agreement with Genmab | 04-Dec-2024 | 07:00 | RNS |
Positive data from Phase 2 SCOPE trial with SCIB1 | 18-Nov-2024 | 07:00 | RNS |
Result of Annual General Meeting | 25-Oct-2024 | 15:26 | RNS |
Currency | UK Pounds |
Share Price | 9.50p |
Change Today | -0.25p |
% Change | -2.56 % |
52 Week High | 19.50 |
52 Week Low | 7.50 |
Volume | 160,390 |
Shares Issued | 1,036.78m |
Market Cap | £98.49m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
15:54 | 400 @ 10.00p |
15:54 | 25,000 @ 9.50p |
13:59 | 12,234 @ 9.70p |
13:22 | 34,341 @ 9.50p |
12:43 | 18 @ 9.85p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research